MedPath

Dexamethasone

Dexamethasone Tablets, USP 4mg and 6 mg Rx only

Approved
Approval ID

3166db4f-66a5-496a-a194-3cc01b7347d3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 1, 2023

Manufacturers
FDA

Bionpharma Inc.,

DUNS: 079637826

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69452-277
Application NumberANDA217001
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dexamethasone
Product Specifications
Route of AdministrationORAL
Effective DateAugust 1, 2023
FDA Product Classification

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
DEXAMETHASONEActive
Quantity: 4 mg in 1 1
Code: 7S5I7G3JQL
Classification: ACTIB

Dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69452-278
Application NumberANDA217001
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dexamethasone
Product Specifications
Route of AdministrationORAL
Effective DateAugust 1, 2023
FDA Product Classification

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
DEXAMETHASONEActive
Quantity: 6 mg in 1 1
Code: 7S5I7G3JQL
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dexamethasone - FDA Drug Approval Details